Literature DB >> 19906104

RNAi-mediated silencing of ezrin gene reverses malignant behavior of human gastric cancer cell line SGC-7901.

Hong Jian Wang1, Jin Shui Zhu, Qiang Zhang, Hua Guo, Yun Hai Dai, Xiao Peng Xiong.   

Abstract

OBJECTIVE: To investigate the effects of ezrin targeting gene of RNA interference (RNAi) on human gastric cancer cell line SGC-7901 in vitro.
METHODS: The highly metastatic human gastric cancer cell line SGC-7901 transfected with a small interfering (siRNA) lentivirus vector was selected for this research study. Expressions of ezrin mRNA and ezrin protein in the SGC-7901 cells were detected using RT-PCR and Western blot. Cell apoptosis was observed using flow cytometry. Transwell invasion and the cell adhesion test were used to verify the effect of RNAi on ezrin expression in the human gastric cancer cell line SGC-7901 in vitro.
RESULTS: Ezrin gene targeting via a RNAi-mediated lentivirus vector had obvious inhibitory effects on ezrin expression in the human gastric cancer cell line SGC-7901. The results of the RT-PCR show the obvious inhibition of ezrin mRNA expression in Eai and Ebi groups (0.22 +/- 0.01 vs 0.95 +/- 0.04, P < 0.05; 0.31 +/- 0.01 vs. 0.95 +/- 0.04, P < 0.05). Western blot analysis revealed a 72.35 +/- 3.74% reduction of the ezrin protein level after interference with the ezrin targeting gene. Moreover, the inhibition of ezrin expression clearly inhibited SGC-7901 cell migration and invasion, and improved cell adhesion as well as increased sensitivity to camptothecin-induced apoptosis.
CONCLUSION: Ezrin gene targeting by RNAi can inhibit the metastatic growth and migration of SGC-7901 human gastric cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906104     DOI: 10.1111/j.1751-2980.2009.00394.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  9 in total

1.  Suppression of lung cancer metastasis-related protein 1 (LCMR1) inhibits the growth of colorectal cancer cells.

Authors:  E Ji-Fu; Jun-Jie Xing; Li-Qiang Hao; Chuan-Gang Fu
Journal:  Mol Biol Rep       Date:  2011-07-06       Impact factor: 2.316

2.  Ezrin is associated with gastric cancer progression and prognosis.

Authors:  Li Li; Yuan-Yu Wang; Zhong-Sheng Zhao; Jie Ma
Journal:  Pathol Oncol Res       Date:  2011-06-30       Impact factor: 3.201

3.  Ezrin expression and its phosphorylation in gastric carcinoma with lymphoid stroma and Epstein-Barr virus infection.

Authors:  Taro Tobo; Minako Hirahashi; Takashi Yao; Shinichi Aishima; Yoshinao Oda
Journal:  Mol Clin Oncol       Date:  2012-12-28

4.  Clinicopathological significance of microRNA-214 in gastric cancer and its effect on cell biological behaviour.

Authors:  Ya-Wen Wang; Duan-Bo Shi; Xu Chen; Chao Gao; Peng Gao
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

5.  Resistin, a fat-derived secretory factor, promotes metastasis of MDA-MB-231 human breast cancer cells through ERM activation.

Authors:  Jung Ok Lee; Nami Kim; Hye Jeong Lee; Yong Woo Lee; Su Jin Kim; Sun Hwa Park; Hyeon Soo Kim
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

6.  microRNA-211 regulates cell proliferation, apoptosis and migration/invasion in human osteosarcoma via targeting EZRIN.

Authors:  Yihua Pei; Qin Yao; Yingchao Li; Xin Zhang; Bozhen Xie
Journal:  Cell Mol Biol Lett       Date:  2019-07-09       Impact factor: 5.787

7.  Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.

Authors:  Jingchun Jin; Tiefeng Jin; Meiling Quan; Yingshi Piao; Zhenhua Lin
Journal:  Diagn Pathol       Date:  2012-10-05       Impact factor: 2.644

8.  Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma.

Authors:  Shota Saito; Hiroto Yamamoto; Ken-ichi Mukaisho; Sho Sato; Tomoki Higo; Takanori Hattori; Gaku Yamamoto; Hiroyuki Sugihara
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.

Authors:  Jienan Kong; Chunchan Di; Junjie Piao; Jie Sun; Longzhe Han; Liyan Chen; Guanghai Yan; Zhenhua Lin
Journal:  Oncotarget       Date:  2016-04-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.